At NSN Unlimited, we maintain a large database of parts NDC00172-2053-60, NDC00007-5076-85 with NSN 6505-01-136-4725 used in civil and defense applications for the aerospace, marine, and commercial manufactured by Zenith Laboratories Inc, Glaxosmithkline Llc. Utilize our interface to browse items by part number, part type, manufacturer, and more. Obtain insights on top MRO and FBO services, Manufacturer profiles, and part catalogs.
With an unmatched supply-chain network, we are able to provide expedited shipping and same-day or next-day delivery on qualifying parts.
Ready for a quote? Submit an Instant RFQ today for NSN 6505-01-136-4725.
| Alternative NSN: 6505-01-136-4725 |
| Item Name: Chlorpromazine Hydr |
| NIIN: 011364725 |
| NCB Code: USA (01) |
| Manufacturers: Zenith Laboratories Inc , Glaxosmithkline Llc |
| Part No | NSN | Item Name | Manufacturer | QTY | RFQ |
|---|---|---|---|---|---|
| NDC00172-2053-60 | 6505-01-136-4725 | chlorpromazine hydr | zenith laboratories inc | Avl | RFQ |
| NDC00007-5076-85 | 6505-01-136-4725 | chlorpromazine hydr | glaxosmithkline llc | Avl | RFQ |
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
If You’d Like to Stay Up to Date On Our Latest, Up-To-Date NSN Parts; Kindly Explore Our Catalog and Get Quote for Your Required Part Number.
Request for Quote
